Additional information
| Appearance | |
|---|---|
| EPA Registry Name | Polylactic acid |
| Systematic Name | Injectable Poly-Dl-lactic Acid, Poly(2-hydroxy propionic acid), Polylactic acid, Poly DL-lactide, Ultra-Pure PDLLA |
| Substance Type | Biodegradable Polymer, DL- Lactide 100%, Ester terminated, Excipient, Inherent Viscosity : 1.3 – 1.7 dL/g, Nanoparticles, Non-Active pharmaceutical ingredient, DL10014E |
| Applications | ACL Scrow, bioresorbable implants, Drug delivery formulations |
| Synonym(s) | PDLLA, Poly(DL-lactide) acid terminated, DLPLA |
| Solubility | |
| FT NMR (PROTON) | |
| Viscosity (0.5% in CHCl3 at 30°C) | |
| FT IR | |
| Residual monomer DL-Lactide | |
| Residual solvent acetone | |
| Residual solvent toluene | |
| Acid number | |
| Heavy metal | |
| Tin | |
| Sulphated Ash | |
| TAMC | |
| TYMC | |
| Bacterial Endotoxins | |
| Self life | |
| End Group | Ester terminated |
| Molecular Weight | 190,000 – 240,000 da |
